AG002KRR

210421-74-2 | 3-Thiophenesulfonamide, N-(4-chloro-3-methyl-5-isoxazolyl)-2-[2-(6-methyl-1,3-benzodioxol-5-yl)acetyl]-, sodium salt (1:1)

AG002KRR

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	210421-74-2
Catalog Number	AG002KRR(AGN-PC-0QX8XI)
Chemical Name	3-Thiophenesulfonamide, N-(4-chloro-3-methyl-5-isoxazolyl)-2-[2-(6-methyl-1,3-benzodioxol-5-yl)acetyl]-, sodium salt (1:1)
EC Number	606-692-6
IUPAC Name	sodium;(4-chloro-3-methyl-1,2-oxazol-5-yl)-[2-[2-(6-methyl-1,3-benzodioxol-5-yl)acetyl]thiophen-3-yl]sulfonylazanide
InChI	InChI=1S/C18H14ClN2O6S2.Na/c1-9-5-13-14(26-8-25-13)7-11(9)6-12(22)17-15(3-4-28-17)29(23,24)21-18-16(19)10(2)20-27-18;/h3-5,7H,6,8H2,1-2H3;/q-1;+1
InChI Key	MDTNUYUCUYPIHE-UHFFFAOYSA-N
MDL Number	MFCD11040990
Molecular Formula	C18H14ClN2NaO6S2
Molecular Weight	476.8863
SMILES	O=C(c1sccc1S(=O)(=O)[N-]c1onc(c1Cl)C)Cc1cc2OCOc2cc1C.[Na+]
UNII	6V9JH46E20
Synonyms	Sitaxsentan sodium, Sitaxentan sodium, 210421-74-2, Thelin, Sitaxsentan (sodium), UNII-6V9JH46E20, Sodium (4-chloro-3-methyl-1,2-oxazol-5-yl)-[2-[2-(6-methyl-1,3-benzodioxol-5-yl)acetyl]thiophen-3-yl]sulfonylazanide, TBC-11251NA, 6V9JH46E20, TBC-11251Z, AK136075, Sitaxentan sodium [USAN], IPI 1040, TBC 11251, SITAXSENTANSODIUM, Sitax, PF-1228305, TBC11251 sodium salt, Sitaxsentan sodium [USAN], TBC 11251 sodium salt, CHEMBL2105740, CTK8E9853, AOB6733, MDTNUYUCUYPIHE-UHFFFAOYSA-N, HMS3651J14, BCP08362, KS-000000OP, ABP001069, MFCD11040990, AKOS022171691, API0004185, CS-0364, RL02597, SB19552, AC-24852, AS-16964, BC680162, HY-11103, SC-96754, Sitaxentan sodium salt, >=98% (HPLC), AX8227221, RT-015713, ST2407570, FT-0674604, S-185, SW219294-1, A11564, W-5460, 421S742, J-013795, J-524245, (4-chloro-3-methyl-1,2-oxazol-5-yl)-[2-[2-(6-methyl-1,3-benzodioxol-5-yl)acetyl]thiophen-3-yl]sulfonylazanide sodium., 3-Thiophenesulfonamide, N-(4-chloro-3-methyl-5-isoxazolyl)-2-((6-methyl-1,3-benzodioxol-5-yl)acetyl)-, sodium salt, 4-Chloro-3-methyl-5-(2-(2-(6-methyl-1,3-benzodioxol-5-yl)acetyl)-3-thienylsulfonamido)isoxazole sodium salt, N-(4-Chloro-3-methyl-5-isoxazolyl)-2-[2-(6-methyl-1,3-benzodioxol-5-yl)acetyl]-3-thiophenesulfonamide Sodium, sodium (4-chloro-3-methylisoxazol-5-yl)((2-(2-(6-methylbenzo[d][1,3]dioxol-5-yl)acetyl)thiophen-3-yl)sulfonyl)amide, sodium,(4-chloro-3-methyl-1,2-oxazol-5-yl)-[2-[2-(6-methyl-1,3-benzodioxol-5-yl)acetyl]thiophen-3-yl]sulfonylazanide, sodium;(4-chloro-3-methyl-1,2-oxazol-5-yl)-[2-[2-(6-methyl-1,3-benzodioxol-5-yl)acetyl]thiophen-3-yl]sulfonylazanide, D08JWJ, TBC-11251, CID6918326, CID11477084, B1522, 210421-64-0,

Complexity	726
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	2
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Exact Mass	475.988g/mol
Formal Charge	0
Heavy Atom Count	30
Hydrogen Bond Acceptor Count	9
Hydrogen Bond Donor Count	0
Isotope Atom Count	0
Molecular Weight	476.878g/mol
Monoisotopic Mass	475.988g/mol
Rotatable Bond Count	6
Topological Polar Surface Area	133A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class
Hazard statements	H315-H319-H335
Packing Group
Precautionary statements	P261-P305+P351+P338
UN Code

Certificate of Analysis

Lot Number